GGrantIndex
← Leaderboards

Jan Matt Van De Rijn

Stanford University

$4,831,176
Attributed
$6,588,326
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $593.5K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,588,326 · 4

By mechanism

R01$6,283,849 · 2
P50$304,477 · 1
P01$0 · 1

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorBaseMolecularMalignant NeoplasmsSamplingGene Expression ProfilingGene ExpressionMalignant Breast NeoplasmTissuesFormalinParaffin EmbeddingMessenger RnaNovel StrategiesSpecimenNeoplasmsValidationLocationHistologicGenesPrognostic MarkerResponseCarcinomaClassificationNovel Diagnostics

Grant awards (19)

Studying macrophage polarization in search for predictive and prognostic markers of breast cancer$593,531
R01 · FY2025 · CA · contact PI
Macrophage phenotype polarization in clinical neoplasia$539,085
R01 · FY2022 · CA · contact PI
Macrophage phenotype polarization in clinical neoplasia$550,086
R01 · FY2021 · CA · contact PI
Macrophage phenotype polarization in clinical neoplasia$550,086
R01 · FY2020 · CA · contact PI
Macrophage phenotype polarization in clinical neoplasia$533,583
R01 · FY2019 · CA · contact PI
Macrophage phenotype polarization in clinical neoplasia$550,086
R01 · FY2018 · CA · contact PI
Clinically relevant molecular subtypes in leiomyosarcoma$328,575
R01 · FY2014 · CA · contact PI
Clinically relevant molecular subtypes in leiomyosarcoma$318,412
R01 · FY2013 · CA · contact PI
Clinically relevant molecular subtypes in leiomyosarcoma$338,737
R01 · FY2012 · CA · contact PI
Clinically relevant molecular subtypes in leiomyosarcoma$338,778
R01 · FY2011 · CA · contact PI
Clinically relevant molecular subtypes in leiomyosarcoma$157,360
R01 · FY2010 · CA · contact PI
Molecular Characterization of Leiomyosarcoma and GIST$292,135
R01 · FY2009 · CA · contact PI
Molecular Characterization of Leiomyosarcoma and GIST$292,135
R01 · FY2008 · CA · contact PI
Molecular Characterization of Leiomyosarcoma and GIST$292,135
R01 · FY2007 · CA · contact PI
Molecular Characterization of Leiomyosarcoma and GIST$300,860
R01 · FY2006 · CA · contact PI
Molecular Characterization of Leiomyosarcoma and GIST$308,265
R01 · FY2005 · CA
Core--Morphology /gene expression$158,638
P50 · FY2005 · HL
Core--Morphology /gene expression$145,839
P50 · FY2002 · HL
Core--Morphology /gene expression$0
P01 · FY2001 · HL